SCHEMBL3821049

SCHEMBL3821049

CCOC(=O)c1nc(C)c(CN)s1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.44
CYP1A2 P05177 2/20 0.44
HPGD P15428 3/20 0.43
MAPT P10636 3/20 0.43
GAA P10253 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
LMNA P02545 1/20 0.41
FHIT P49789 1/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
HSD17B10 Q99714 2/20 0.39
KDM4E B2RXH2 1/20 0.39
CDC7 O00311 1/20 0.38
DBF4 Q9UBU7 1/20 0.38
PDE4D Q08499 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3823404 0.85 ALDH1A1 (0.45) ALDH1A1CYP1A2HPGDMAPTGAA
SCHEMBL3823328 0.83 ALDH1A1 (0.41) ALDH1A1CYP1A2HPGDMAPTGAA
SCHEMBL1503950 0.79 ALDH1A1 (0.45) ALDH1A1CYP1A2HPGDMAPTGAA
SCHEMBL30037122 0.78 ALDH1A1 (0.40) ALDH1A1CYP1A2HPGDMAPTGAA
SCHEMBL3827730 0.77 ALDH1A1 (0.50) ALDH1A1CYP1A2HPGDMAPTGAA
SCHEMBL10206331 0.76 ALDH1A1 (0.36) ALDH1A1CYP1A2HPGDMAPTGAA
SCHEMBL289991 0.76 ALDH1A1 (0.43) ALDH1A1CYP1A2HPGDMAPTGAA
SCHEMBL3824920 0.75 ALDH1A1 (0.49) ALDH1A1CYP1A2HPGDMAPTSMN1; SMN2
SCHEMBL1560369 0.75 TRPM8 (0.42) ALDH1A1CYP1A2HPGDMAPTGAA
SCHEMBL6114078 0.75 ALDH1A1 (0.53) ALDH1A1CYP1A2HPGDMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2096111-A1 PYRAZOLES AND USE THEREOF AS DRUGS Japan Tobacco Inc. (JP) 2009-09-02 EP claimed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US claimed
EP-2096111-A1 PYRAZOLES AND USE THEREOF AS DRUGS Japan Tobacco Inc. (JP) 2009-09-02 EP disclosed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US disclosed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US disclosed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF PYGL, GYS2, G6PC1 ALDH1A1 775/4885CYP1A2 172/4885HPGD 675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.